Page last updated: 2024-08-22

galactosamine and stilbenes

galactosamine has been researched along with stilbenes in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (83.33)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Farghali, H; Kemelo, MK; Kutinová Canová, N; Wojnarová, L1
Farghali, H; Kgalalelo Kemelo, M; Kutinová Canová, N; Wojnarová, L1
Gong, XB; Jia, YN; Lu, HP; Pan, MH; Peng, YL; Su, J; Xu, L; Zhang, BS; Zhou, Y1
Li, S; Lin, H; Siu, FY; Ye, S1
Jia, A; Lin, H; Tao, L; Wen, J; Weng, D; Xu, X; Yang, Y; Zhang, J; Zhao, M1
Du, C; Jiang, A; Li, S; Liu, Z; Wang, J; Wu, D; Xie, G; Zhang, Y1

Reviews

1 review(s) available for galactosamine and stilbenes

ArticleYear
In vitro and in vivo experimental hepatotoxic models in liver research: applications to the assessment of potential hepatoprotective drugs.
    Physiological research, 2016, 12-21, Volume: 65, Issue:Suppl 4

    Topics: Animals; Biomedical Research; Disease Models, Animal; Down-Regulation; Drug Discovery; Galactosamine; Humans; Lipopolysaccharides; Liver Failure, Acute; Protective Agents; Resveratrol; Sirtuin 1; Stilbenes

2016

Other Studies

5 other study(ies) available for galactosamine and stilbenes

ArticleYear
D-galactosamine/lipopolysaccharide-induced hepatotoxicity downregulates sirtuin 1 in rat liver: role of sirtuin 1 modulation in hepatoprotection.
    Physiological research, 2014, Volume: 63, Issue:5

    Topics: Animals; Antioxidants; Carbazoles; Chemical and Drug Induced Liver Injury; Cytoprotection; Disease Models, Animal; Down-Regulation; Enzyme Inhibitors; Galactosamine; Lipid Peroxidation; Lipopolysaccharides; Liver; Male; Rats, Wistar; Resveratrol; Sirtuin 1; Stilbenes

2014
Oxyresveratrol prevents lipopolysaccharide/d-galactosamine-induced acute liver injury in mice.
    International immunopharmacology, 2018, Volume: 56

    Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Cells, Cultured; Chemical and Drug Induced Liver Injury; Galactosamine; Heme Oxygenase-1; Hepatocytes; Kelch-Like ECH-Associated Protein 1; Lipopolysaccharides; Liver; Male; Membrane Proteins; Mice; Mice, Inbred Strains; Morus; NAD(P)H Dehydrogenase (Quinone); NF-E2-Related Factor 2; NF-kappa B; Plant Extracts; Signal Transduction; Stilbenes; Toll-Like Receptor 4

2018
Galactosylated PLGA nanoparticles for the oral delivery of resveratrol: enhanced bioavailability and in vitro anti-inflammatory activity.
    International journal of nanomedicine, 2018, Volume: 13

    Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Biological Availability; Caco-2 Cells; Drug Liberation; Endocytosis; Galactosamine; Humans; Inflammation; Intestinal Absorption; Intestinal Mucosa; Lactic Acid; Male; Nanoparticles; Particle Size; Permeability; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Proton Magnetic Resonance Spectroscopy; Rats, Sprague-Dawley; Resveratrol; Solubility; Stilbenes

2018
Piceatannol attenuates D-GalN/LPS-induced hepatoxicity in mice: Involvement of ER stress, inflammation and oxidative stress.
    International immunopharmacology, 2018, Volume: 64

    Topics: Animals; Anti-Inflammatory Agents; Cells, Cultured; Cytokines; Endoplasmic Reticulum Stress; Female; Galactosamine; Lipopolysaccharides; Liver; Liver Failure, Acute; Mice; Mice, Inbred C57BL; Oxidative Stress; Reactive Oxygen Species; Stilbenes

2018
Pterostilbene Exerts Hepatoprotective Effects through Ameliorating LPS/D-Gal-Induced Acute Liver Injury in Mice.
    Inflammation, 2021, Volume: 44, Issue:2

    Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Antioxidants; Biomarkers; Blotting, Western; Cytokines; Enzyme-Linked Immunosorbent Assay; Galactosamine; Lipopolysaccharides; Liver; Male; Mice; Mice, Inbred BALB C; Protective Agents; Random Allocation; Real-Time Polymerase Chain Reaction; Stilbenes; Treatment Outcome

2021